Check Capital Management Inc Amgen Inc Transaction History

Check Capital Management Inc

$2.72 Billion
Q2 2024

A detailed history of Check Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Check Capital Management Inc holds 3,720 shares of AMGN stock, worth $1.24 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,720

Previous 3,720 -0.0%

Holding current value

$1.24 Million

Previous $1.06 Million 9.93%

% of portfolio

0.04%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $11,535 - $12,837	-50 Reduced 1.33%	3,720 $905,000
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $9,764 - $11,378	-44 Reduced 1.15%	3,770 $938,000
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $9,953 - $11,852	46 Added 1.22%	3,814 $877,000
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $47,399 - $52,711	-202 Reduced 5.09%	3,768 $957,000
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $1,978 - $2,427	-10 Reduced 0.25%	3,970 $936,000

Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $92,395 - $122,541	-507 Reduced 11.3%	3,980 $807,000
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $1,324 - $1,702	-7 Reduced 0.16%	4,487 $1.08 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $6,616 - $7,927	-38 Reduced 0.84%	4,494 $870,000
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $15,916 - $17,941	-88 Reduced 1.9%	4,532 $861,000
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $274,736 - $320,705	1,540 Added 50.0%	4,620 $899,000
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $515,253 - $588,280	-3,080 Reduced 50.0%	3,080 $574,000
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $515,253 - $588,280	3,080 Added 100.0%	6,160 $1.15 Million
Q2 2017 Aug 11, 2017	BUY	N/A	3,080	3,080 $530,000

Others Institutions Holding AMGN

# of Institutions

2,977

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.61M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Check Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Check Capital Management Inc with notifications on news.

Account

Check Capital Management Inc Amgen Inc Transaction History